Abstract:Background Previous studies have demonstrated that exposure to nickel nanoparticles (Nano-Ni) causes oxidative stress and severe, persistent lung inflammation, which are strongly associated with pulmonary toxicity. However, few studies have investigated whether surface modification of Nano-Ni could alter Nano-Ni-induced lung injury, inflammation, and fibrosis in vivo. Here, we propose that alteration of physicochemical properties of Nano-Ni through modification of Nano-Ni surface may change Nano-Ni-induced lung injury, inflammation, and fibrosis. Methods At first, dose–response and time-response studies were performed to observe lung inflammation and injury caused by Nano-Ni. In the dose–response studies, mice were intratracheally instilled with 0, 10, 20, 50, and 100 μg per mouse of Nano-Ni and sacrificed at day 3 post-exposure. In the time-response studies, mice were intratracheally instilled with 50 µg per mouse of Nano-Ni and sacrificed at days 1, 3, 7, 14, 28, and 42 post-instillation. At the end of the experiment, mice were bronchoalveolar lavaged (BAL) and the neutrophil count, CXCL1/KC level, LDH activity, and concentration of total protein in the BAL fluid (BALF) were determined. In the comparative studies, mice were intratracheally instilled with 50 μg per mouse of Nano-Ni or with the same molar concentration of Ni as Nano-Ni of either partially [O]-passivated Nano-Ni (Nano-Ni–P) or carbon-coated Nano-Ni (Nano-Ni–C). At day 3 post-exposure, BAL was performed and the above cellular and biochemical parameters in the BALF were analyzed. The MMP-2/9 protein levels and activities in the BALF and mouse lung tissues were also determined. Mouse lung tissues were also collected for H&E staining, and measurement of thiobarbituric acid reactive substances (TBARS) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in the genomic DNA. At day 42 post-exposure, mouse right lung tissues were collected for H&E and Trichrome stainings, and left lung tissues were collected to determine the hydroxyproline content. Results Exposure of mice to Nano-Ni resulted in a dose–response increase in acute lung inflammation and injury reflected by increased neutrophil count, CXCL1/KC level, LDH activity, and concentration of total protein in the BALF. The time-response study showed that Nano-Ni-induced acute lung inflammation and injury appeared as early as day 1, peaked at day 3, and attenuated at day 7 post-instillation. Although the neutrophil count, CXCL1/KC level, LDH activity, and concentration of total protein in the BALF dramatically decreased over the time, their levels were still higher than those of the controls even at day 42 post-exposure. Based on the results of the dose- and time-response studies, we chose a dose of 50 µg per mouse of Nano-Ni, and day 3 post-exposure as short-term and day 42 post-exposure as long-term to compare the effects of Nano-Ni, Nano-Ni–P, and Nano-Ni–C on mouse lungs. At day 3 post-exposure, 50 μg per mouse of Nano-Ni caused acute lung inflammation and injury that were reflected by increased neutrophil count, CXCL1/KC level, LDH activity, concentration of total protein, and MMP-2/9 protein levels and activities in the BALF. Nano-Ni exposure also caused increased MMP-2/9 activities in the mouse lung tissues. Histologically, infiltration of large numbers of neutrophils and macrophages in the alveolar space and interstitial tissues was observed in mouse lungs exposed to Nano-Ni. Nano-Ni–P exposure caused similar acute lung inflammation and injury as Nano-Ni. However, exposure to Nano-Ni–C only caused mild acute lung inflammation and injury. At day 42 post-exposure, Nano-Ni caused extensive interstitial fibrosis and proliferation of interstitial cells with inflammatory cells infiltrating the alveolar septa and alveolar space. Lung fibrosis was also observed in Nano-Ni–P-exposed lungs, but to a much lesser degree. Only slight or no lung fibrosis was observed in Nano-Ni–C-exposed lungs. Nano-Ni and Nano-Ni–P, but not Nano-Ni–C, caused significantly elevated levels of TBARS in mouse lung tissues and 8-OHdG in mouse lung tissue genomic DNA, suggesting that Nano-Ni and Nano-Ni–P induce lipid peroxidation and oxidative DNA damage in mouse lung tissues, while Nano-Ni–C does not. Conclusion Our results demonstrate that short-term Nano-Ni exposure causes acute lung inflammation and injury, while long-term Nano-Ni exposure causes chronic lung inflammation and fibrosis. Surface modification of Nano-Ni alleviates Nano-Ni-induced pulmonary effects; partially passivated Nano-Ni causes similar effects as Nano-Ni, but the chronic inflammation and fibrosis were at a much lesser degree. Carbon coating significantly alleviates Nano-Ni-induced acute and chronic lung inflammation and injury.

Murine Liver Damage Caused by Exposure to Nano-Titanium Dioxide

Cardiac oxidative damage in mice following exposure to nanoparticulate titanium dioxide.

The nano-TiO 2 exposure can induce hepatic inflammation involving in a JAK–STAT signalling pathway

The Potential Liver, Brain, and Embryo Toxicity of Titanium Dioxide Nanoparticles on Mice

Liver Inflammation and Fibrosis Induced by Long-Term Exposure to Nano Titanium Dioxide (TiO<sub>2</sub>) Nanoparticles in Mice and Its Molecular Mechanism

Multiscale Nano-Tio2 On Oxidative Damage In The Liver, Kidney And Spleen Of Mice

Oxidative Stress Increased Hepatotoxicity Induced by Nano-Titanium Dioxide in Brl-3a Cells and Sprague-Dawley Rats

In Vivo Acute Toxicity of Titanium Dioxide Nanoparticles to Mice after Intraperitioneal Injection

Gene Expression in Liver Injury Caused by Long-Term Exposure to Titanium Dioxide Nanoparticles in Mice.

Rethinking Nano‐TiO 2 Safety: Overview of Toxic Effects in Humans and Aquatic Animals

Health Effects of Exposure to Nano-Tio2: a Meta-Analysis of Experimental Studies

Nano-sized Titanium Dioxide-Induced Splenic Toxicity: A Biological Pathway Explored Using Microarray Technology

Comparative Mouse Lung Injury by Nickel Nanoparticles with Differential Surface Modification

Genotoxicity and Gene Expression Analyses of Liver and Lung Tissues of Mice Treated with Titanium Dioxide Nanoparticles.

TiO 2 Nanoparticles Caused DNA Damage in Lung and Extra-Pulmonary Organs Through ROS-Activated FOXO3a Signaling Pathway After Intratracheal Administration in Rats

Toxicological Characteristics of Nanoparticulate Anatase Titanium Dioxide in Mice

TiO2 Nanoparticles Caused DNA Damage in Lung and Extra-Pulmonary Organs Through ROS-Activated FOXO3a Signaling Pathway After Intratracheal Administration in Rats

Oxidative Damage of Lung and Its Protective Mechanism in Mice Caused by Long-Term Exposure to Titanium Dioxide Nanoparticles.

Acute Toxicity of Intravenously Administered Titanium Dioxide Nanoparticles in Mice

Mitochondrial Injury Induced by Nanosized Titanium Dioxide in A549 Cells and Rats.

Titanium dioxide nanoparticles Disrupt ultrastructure and function of Rat thyroid tissue via oxidative stress